Alerts will be sent to your verified email
Verify Email
VAISHALI
|
Vaishali Pharma
|
Concord Drugs
|
Denis Chem Lab
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
7.83 % | 2.78 % | 9.47 % |
|
5yr average Equity Multiplier
|
2.48 | 1.87 | 1.4 |
|
5yr Average Asset Turnover Ratio
|
0.88 | 0.84 | 1.46 |
|
5yr Avg Net Profit Margin
|
3.68 % | 1.59 % | 4.57 % |
|
Price to Book
|
1.53 | 2.99 | 1.22 |
|
P/E
|
0.0 | 178.46 | 14.94 |
|
5yr Avg Cash Conversion Cycle
|
87.63 Days | 233.27 Days | 5.37 Days |
|
Inventory Days
|
6.87 Days | 152.22 Days | 23.69 Days |
|
Days Receivable
|
177.19 Days | 106.22 Days | 65.58 Days |
|
Days Payable
|
159.49 Days | 74.71 Days | 89.52 Days |
|
5yr Average Interest Coverage Ratio
|
2.55 | 1.69 | 17.08 |
|
5yr Avg ROCE
|
15.65 % | 8.41 % | 13.68 % |
|
5yr Avg Operating Profit Margin
|
5.99 % | 9.1 % | 10.7 % |
|
5 yr average Debt to Equity
|
0.48 | 0.55 | 0.05 |
|
5yr CAGR Net Profit
|
-4.82 % | -26.55 % | 29.02 % |
|
5yr Average Return on Assets
|
3.24 % | 1.46 % | 6.85 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
31.61 % | 54.39 % | 38.98 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
4.87 % | 5.39 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Vaishali Pharma
|
Concord Drugs
|
Denis Chem Lab
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|